NCT02177500 Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy Status COMPLETED Phase PHASE3
NCT02177487 Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension Status COMPLETED Phase PHASE3
NCT02177461 Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension Status COMPLETED Phase PHASE4
NCT02177435 Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension Status COMPLETED Phase PHASE3
NCT02177422 Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension Status COMPLETED Phase PHASE3
NCT02177409 Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension Status COMPLETED Phase PHASE3
NCT02177396 MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring Status COMPLETED Phase PHASE3
NCT02177370 Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma Status TERMINATED Phase PHASE3
NCT02177357 Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients Status COMPLETED Phase PHASE3
NCT02177344 Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT02177331 Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension Status COMPLETED Phase PHASE3
NCT02177318 Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02177305 Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02177253 Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT02176850 Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension Status COMPLETED Phase N/A
NCT02176564 Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02176525 Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients Status COMPLETED Phase PHASE1
NCT02176512 Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02176499 Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension Status COMPLETED Phase PHASE3